// STATE LEGISLATION TRACKER

Ohio HB 455: Regards the operation of public schools and the DEW

⚖️ NEUTRAL for peptide users 👤 NONE user impact 📜 Status: Signed

State: Ohio
Bill: HB 455
Session: 136
Filed: 2025-09-17
Read the bill: OpenStates →
Last reviewed: 2026-10-02

Plain-English Summary

Ohio HB455 is an education bill about public school operations and the Department of Education and Workforce. Based on the title, subjects, and effective status, it does not appear to change peptide prescribing, compounding, telehealth, clinician scope, controlled substances, or prescription monitoring.

Key Points

No clear change to compounded peptide access
No apparent impact on off-label peptide prescribing
No telehealth or clinic access change indicated
No peptide-specific FDA 503A or 503B issue flagged

What to Watch For

Note Bill is effective October 9, 2026, so any school-related changes are now active.

Note Health-related peptide clinics should not treat this as a prescribing or compounding law change.

Note Any drug references appear tied to school operations, not adult peptide access or clinic practice.

Where the Bill Stands

The bill has completed the legislative process and is listed as effective on October 9, 2026.

· Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.

Bill page generated 2026-11-04 · enriched via codex gpt-5.5
Source: OpenStates v3 API · View official bill · ← back to all laws